The Extended Gestational Age Medical Abortion Study

• Status: Completed
• Trial end date: 2012-02-01
• Target enrollment: 0
• Participant gender: Female

Summary

This open-label, comparative study will compare the efficacy, safety, and acceptability of 200 mg mifepristone followed in 24-48 hours by 800mcg buccal misoprostol or 400mcg sublingual misoprostol for termination of pregnancy in existing outpatient early medical abortion services among women 57-63 days' versus 64-70 days' gestation.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Gynuity Health Projects
• Treatments: Mifepristone; Misoprostol

Criteria

Inclusion Criteria:

• intrauterine pregnancy of greater than 56 days and less than 71 days

• eligible for medical abortion according to study doctor assessment

• willing and able to sign consent forms

• speak English or Spanish (in US sites); speak the local language(s) (in international sites)

• agree to comply with the study procedures and visit schedule